Encuragen
Anyang
About Encuragen
Encuragen develops biological therapeutics for the treatment of incurable diseases and the improvement of human health. EncuraGen engages in scientific research to find fundamental cures for patients suffering from various difficult-to-cure diseases, rather than simply alleviating symptoms. EncuraGen is committed to the research and development of novel medicines in order to provide comprehensive therapeutics for cure and care. Furthermore, the company is a specialized, dedicated R&D company engaged in synthetic biology, which will open up a new horizon for prospective industries through the broad, creative application of basic life sciences.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Mar 2021)
- Website: encuragen.com
- Phone: +82-31-360-3132
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/encuragen-2692001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.